Peer-Reviewed Publications

Kurve Therapeutics’ innovative technology and drug formulations have been featured in 17 peer-reviewed publications in leading medical journals with further publications pending.

We have recent and ongoing collaborations with leading research centers including Harvard, Johns Hopkins, and the Karolinska Institute.

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson’s disease and multiple system atrophy
Acetyl-L-Carnitine Deficiency in Patients with Major Depressive Disorder
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder
November 2017
Effect of intranasally administered insulin on cerebral blood flow and perfusion
March 14, 2017
Johns Hopkins: Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer’s Disease Dementia, Phase I
Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes
September 23, 2014
Intranasal insulin: is there a promise for treatment of diabetes-related cognitive decline?
April 4, 2014
Acute Effects of Intranasal Insulin on Regional Cerebral Perfusion and Cognition in Type 2 Diabetes
March 2014
Intranasal Insulin Therapy for Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
Intranasal insulin improves cognition and modulates beta-amyloid in early AD
Antidiabetic Agents Show Some Promise in Treating Alzheimer\'s Disease
In Vivo Double-blind Insulin Study; Early AD or MCI
Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype
Deposition Comparison: A Scintigraphic Study; ViaNase™ with Controlled Particle Dispersion® (CPD), Spray Pump and Nebulizer Deposition Comparison